Structural characterization of phospholamban in cardiac sarcoplasmic reticulum membranes by cross-linking.
The native form of phospholamban in cardiac sarcoplasmic reticulum membranes was investigated using photosensitive heterobifunctional cross-linkers, both cleavable and noncleavable, and common protein modifiers. The photosensitive heterobifunctional cleavable cross-linker ethyl 4-azidophenyl-1, 4-dithiobutyrimidate was used in native SR vesicles and it cross-linked phospholamban into an apparent phospholamban-phospholamban dimer and into an approximately 110,000-Da species. The phospholamban dimer migrated at approximately 12,000 Da on sodium dodecyl sulfate-polyacrylamide gels, and upon cleavage of the cross-linker before electrophoresis the dimer disappeared. The approximately 110,000-Da cross-linked species was not affected by boiling in sodium dodecyl sulfate prior to electrophoresis. This cross-linked form of phospholamban migrated approximately 5500 Da above the Ca2(+)-ATPase, which was visualized using fluorescein 5'-isothiocynate, a fluorescent marker that binds specifically to the Ca2(+)-ATPase. p-Azidophenacyl bromide, iodoacetic acid, and N-ethylmaleimide, all of which react with sulfhydryl groups, were also employed to further characterize phospholamban in native sarcoplasmic reticulum membranes. Cross-linking with p-azidophenacyl bromide resulted in only monomeric and dimeric forms of phospholamban as observed on sodium dodecyl sulfate-polyacrylamide gels. Iodoacetic acid and N-ethylmalemide were found to be effective in disrupting the pentameric form of phospholamban only when reacted with sodium dodecyl sulfate solubilized sarcoplasmic reticulum. In view of these findings, the amino acid sequence of phospholamban was examined for possible protein-protein interaction sites. Analysis by hydropathic profiling and secondary structure prediction suggests that the region of amino acids 1-14 may form an amphipathic alpha helix and the hydrophobic surface on one of its sites could interact with the reciprocal hydrophobic surface of another protein, such as the Ca2(+)-ATPase.
Young
E F
EF
Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, OH 45267-0575.
McKee
M J
MJ
Ferguson
D G
DG
Kranias
E G
EG
D000595:Amino Acid Sequence; D000818:Animals; D000906:Antibodies; D001386:Azides; D015153:Blotting, Western; D002135:Calcium-Binding Proteins / Q000302:isolation & purification; D003432:Cross-Linking Reagents; D004285:Dogs; D007425:Intracellular Membranes / Q000032:analysis*; D008969:Molecular Sequence Data; D008970:Molecular Weight; D009206:Myocardium / Q000032:analysis* / Q000648:ultrastructure; D011487:Protein Conformation; D012519:Sarcoplasmic Reticulum / Q000032:analysis*; D000099211:Phospholamban
D000906:Antibodies; D001386:Azides; D002135:Calcium-Binding Proteins; D003432:Cross-Linking Reagents; D000099211:Phospholamban; C063819:ethyl 4-azidophenyl-1,4-dithiobutyrimidate